We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $25B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+18.87%
3 Year Est. Return
+73.23%
5 Year Est. Return
+90.52%
10 Year Est. Return
+458.69%
AUM
$3.19B
AUM Growth
+$153M
Cap. Flow
+$17.6M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.55%
Holding
324
New
11
Increased
97
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$27.5M
2
BSX icon
Boston Scientific
BSX
+$25.3M
3
LW icon
Lamb Weston
LW
+$6.07M
4
ADSK icon
Autodesk
ADSK
+$5.95M
5
FCFS icon
FirstCash
FCFS
+$5.8M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$34.4M
2
BKNG icon
Booking.com
BKNG
+$22.2M
3
WEC icon
WEC Energy
WEC
+$7.17M
4
MS icon
Morgan Stanley
MS
+$4.67M
5
INTC icon
Intel
INTC
+$4.26M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Financials 20.16%
3 Healthcare 11.15%
4 Consumer Staples 11.15%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCN
26
Waste Connections
WCN
$43.4B
$37.6M 1.18%
392,968
-350
-0.1% -$32.3K
ABT icon
27
Abbott
ABT
$177B
$37.5M 1.17%
445,559
+52,874
+13% +$4.16M
MKC icon
28
McCormick & Company Non-Voting
MKC
$14B
$37.3M 1.17%
480,710
CSGP icon
29
CoStar Group
CSGP
$12.1B
$36.8M 1.15%
664,390
ROL icon
30
Rollins
ROL
$21.5B
$36.7M 1.15%
1,535,325
-3,000
-0.2% -$77.3K
NFLX icon
31
Netflix
NFLX
$285B
$36.5M 1.14%
994,240
+11,350
+1% +$409K
BSX icon
32
Boston Scientific
BSX
$65.1B
$34M 1.06%
791,371
+658,328
+495% +$25.3M
JPM icon
33
JPMorgan Chase
JPM
$901B
$33.4M 1.05%
298,884
-8,682
-3% -$957K
COST icon
34
Costco
COST
$415B
$33.4M 1.05%
126,355
+441
+0.4% +$110K
MNST icon
35
Monster Beverage
MNST
$93.4B
$33.1M 1.04%
1,036,000
+83,400
+9% +$2.51M
FRC
36
DELISTED
First Republic Bank
FRC
$33M 1.03%
338,106
+2,191
+0.7% +$221K
JNJ icon
37
Johnson & Johnson
JNJ
$599B
$32.1M 1%
230,220
-198
-0.1% -$27.4K
LW icon
38
Lamb Weston
LW
$6.43B
$32.1M 1%
506,000
+92,000
+22% +$6.07M
FCFS icon
39
FirstCash
FCFS
$9.19B
$32M 1%
320,000
+61,000
+24% +$5.8M
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.06T
$32M 1%
150,025
-6,166
-4% -$1.28M
NVDA icon
41
NVIDIA
NVDA
$4.92T
$31.7M 0.99%
7,715,520
+1,202,600
+18% +$4.98M
TXN icon
42
Texas Instruments
TXN
$259B
$31.7M 0.99%
275,830
+29,821
+12% +$3.34M
DIS icon
43
Walt Disney
DIS
$167B
$30.4M 0.95%
217,656
-1,023
-0.5% -$136K
IDXX icon
44
Idexx Laboratories
IDXX
$44.5B
$29.7M 0.93%
107,900
CME icon
45
CME Group
CME
$88.6B
$29.6M 0.93%
152,736
-108
-0.1% -$19.9K
MO icon
46
Altria Group
MO
$125B
$29.5M 0.93%
624,012
-2,137
-0.3% -$112K
GDDY icon
47
GoDaddy
GDDY
$12.6B
$27.5M 0.86%
392,000
RNG icon
48
RingCentral
RNG
$3.42B
$27.4M 0.86%
+238,300
New +$27.5M
AOS icon
49
A.O. Smith
AOS
$8.12B
$23.5M 0.74%
498,000
-1,700
-0.3% -$83.4K
PFE icon
50
Pfizer
PFE
$141B
$22.1M 0.69%
537,705
+2,990
+0.6% +$119K

Similar funds

Rathbones Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
  • Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
  • Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
  • Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
  • Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
  • Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
  • Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.

Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.